Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Postepy Higieny I Medycyny Doswiadczalnej (Online)|August 4, 2010
[The role of the proteasome for therapy of incurable diseases]Irena Bubko, Beata M Gruber, Elzbieta L Anuszewska
Folia Histochemica Et Cytobiologica|July 16, 2004
The effect of new anthracycline derivatives on the induction of apoptotic processes in human neoplastic cellsBeata M Gruber, Elzbieta L Anuszewska, Waldemar Priebe
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|May 30, 2019
The application of an in vitro micronucleus test in mouse fibroblast L929 cellsEwa Drozd, Irena Bubko, Karolina Jaworska, et al.
Acta Poloniae Pharmaceutica|January 15, 2011
Possible role of HSP60 in synergistic action of anthracyclines and sulindac in HeLa cellsBeata M Gruber, Jolanta Krzysztoń-Russjan, Irena Bubko, et al.
Biopreservation and Biobanking|June 27, 2022
Quality and Purity of L929 Cell Cultures: Isoenzyme Profiles As a Sensitive Marker of Cross-ContaminationBeata M Gruber-Bzura, Irena Bubko, Paulina Sztybor, et al.
Cancer Genomics & Proteomics|May 18, 2012
Modulation of apoptosis protein profiles--role of P-gp in HeLa cells exposed to doxorubicinBeata M Gruber, Jolanta Krzysztoń-Russjan, Irena Bubko, et al.
Anticancer Research|September 15, 2005
Relationship between topoisomerase II-DNA cleavable complexes, apoptosis and cytotoxic activity of anthracyclines in human cervix carcinoma cellsBeata M Gruber, Elzbieta L Anuszewska, Irena Bubko, et al.
Archivum Immunologiae Et Therapiae Experimentalis|June 9, 2007
Effect of structural modification at the 4, 3', and 2' positions of doxorubicin on topoisomerase II poisoning, apoptosis, and cytotoxicity in human melanoma cellsBeata M Gruber, Elzbieta L Anuszewska, Irena Bubko, et al.
Acta Poloniae Pharmaceutica|May 23, 2007
Topoisomerase II alpha expression and cytotoxicity of anthracyclines in human neoplastic cellsBeata M Gruber, Elzbieta L Anuszewska, Iza Roman, et al.
Acta Poloniae Pharmaceutica|July 19, 2005
Constitutive activation of transcription factor NFkappaB as a possible marker of sensitivity of neoplastic cells to anthracyclinesBeata M Gruber, Elzbieta L Anuszewska, Irena Bubko, et al.
Pageof 3